Impact of endogenous protein C on pulmonary coagulation and injury during lethal H1N1 influenza in mice

American Journal of Respiratory Cell and Molecular Biology

Volumn 45, Issue 4, 2011, Pages 789-794

  Schouten, Marcel ^a   Daan De Boer, J ^a   Van Der Sluijs, Koenraad F ^a   Roelofs, Joris J T H ^a   Van't Veer, Cornelis ^a   Levi, Marcel ^a   Esmon, Charles T ^b   Van Der Poll, Tom ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

Coagulation; Infection; Inflammation; Influenza; Protein C

Indexed keywords

FIBRIN; MONOCLONAL ANTIBODY; PROTEIN C; THROMBIN ANTITHROMBIN COMPLEX;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; HISTOPATHOLOGY; INFLUENZA A (H1N1); LUNG INJURY; LUNG LAVAGE; MALE; MOUSE; NEUTROPHIL; NONHUMAN; THROMBOGENESIS; VIRUS LOAD;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTITHROMBIN III; BLOOD COAGULATION; BRONCHOALVEOLAR LAVAGE FLUID; DISEASE MODELS, ANIMAL; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INJECTIONS, INTRAPERITONEAL; LUNG; LUNG INJURY; MALE; MICE; MICE, INBRED C57BL; NEUTROPHIL INFILTRATION; ORTHOMYXOVIRIDAE INFECTIONS; PEPTIDE HYDROLASES; PNEUMOCYTES; PNEUMONIA, VIRAL; PROTEIN C; THROMBOSIS; TIME FACTORS; VIRAL LOAD;

BACTERIA (MICROORGANISMS); MURINAE; MUS;

EID: 80053653315     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2010-0370OC     Document Type: Article

References (32)

1. Dushoff J, Plotkin JB, Viboud C, Earn DJ, Simonsen L. Mortality due to influenza in the United States-an annualized regression approach using multiple-cause mortality data. Am J Epidemiol 2006;163:181-187. (Pubitemid 43068987)
2. Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A, Sessions WM, Xu X, Skepner E, Deyde V, et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 2009;325:197-201.
3. Blanquer J, Blanquer R, Borrás R, Nauffal D, Morales P, Menéndez R, Subías I, Herrero L, Redón J, Pascual J. Aetiology of community acquired pneumonia in Valencia, Spain: a multicentre prospective study. Thorax 1991;46:508-511.
4. Lauderdale TL, Chang FY, Ben RJ, Yin HC, Ni YH, Tsai JW, Cheng SH, Wang JT, Liu YC, Cheng YW, et al. Etiology of community acquired pneumonia among adult patients requiring hospitalization in Taiwan. Respir Med 2005;99:1079-1086.
5. Schouten M, Wiersinga WJ, Levi M, van der Poll T. Inflammation, endothelium, and coagulation in sepsis. J Leukoc Biol 2008;83:536-545. (Pubitemid 351966862)
6. Levi M, Schultz MJ, Rijneveld AW, van der Poll T. Bronchoalveolar coagulation and fibrinolysis in endotoxemia and pneumonia. Crit Care Med 2003;31:S238-S242. (Pubitemid 36458173)
7. Opal S, Fisher C, Vincent JL. Protein C levels as a prognostic indicator of outcome in sepsis and related diseases - question and answer session after scientific review. Crit Care Med 2000;28:S56.
8. Seeger W, Grube C, Gunther A. Proteolytic cleavage of fibrinogen: amplification of its surfactant inhibitory capacity. Am J Respir Cell Mol Biol 1993;9:239-247.
9. Ware LB, Fang X, Matthay MA. Protein C and thrombomodulin in human acute lung injury. Am J Physiol Lung Cell Mol Physiol 2003;285:L514-L521. (Pubitemid 37022850)
10. Schultz MJ, Millo J, Levi M, Hack CE, Weverling GJ, Garrard CS, van der Poll T. Local activation of coagulation and inhibition of fibrinolysis in the lung during ventilator associated pneumonia. Thorax 2004;59:130-135. (Pubitemid 38223484)
11. Choi G, Schultz MJ, Van Till JW, Bresser P, van der Zee JS, Boermeester MA, Levi M, van der Poll T. Disturbed alveolar fibrin turnover during pneumonia is restricted to the site of infection. Eur Respir J 2004;24:786-789. (Pubitemid 39504432)
12. Choi G, Schultz MJ, Levi M, van der Poll T, Millo JL, Garrard CS. Protein C in pneumonia. Thorax 2005;60:705-706.
13. Rijneveld AW, Weijer S, Bresser P, Florquin S, Vlasuk GP, Rote WE, Spek CA, Reitsma PH, van der Zee JS, Levi M, et al. Local activation of the tissue factor-factor VIIa pathway in patients with pneumonia and the effect of inhibition of this pathway in murine pneumococcal pneumonia. Crit Care Med 2006;34:1725-1730. (Pubitemid 43810055)
14. Gunther A, Mosavi P, Heinemann S, Ruppert C, Muth H, Markart P, Grimminger F, Walmrath D, Temmesfeld-Wollbruck B, Seeger W. Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia - comparison with the acute respiratory distress syndrome. Am J Respir Crit Care Med 2000;161:454-462. (Pubitemid 30129452)
15. Rijneveld AW, Florquin S, Bresser P, Levi M, de Waard V, Lijnen R, van der Zee JS, Speelman P, Carmeliet P, van der Poll T. Plasminogen activator inhibitor type-1 deficiency does not influence the outcome of murine pneumococcal pneumonia. Blood 2003;102:934-939. (Pubitemid 36917786)
16. Mosnier LO, Zlokovic BV, Griffin JH. The cytoprotective protein C pathway. Blood 2007;109:3161-3172. (Pubitemid 46572500)
17. Vail GM, Xie YJ, Haney DJ, Barnes CJ. Biomarkers of thrombosis, fibrinolysis, and inflammation in patients with severe sepsis due to community-acquired pneumonia with and without Streptococcus pneumoniae. Infection 2009;37:358-364.
18. Macias WL, Nelson DR. Severe protein C deficiency predicts early death in severe sepsis. Crit Care Med 2004;32:S223-S228.
19. Schouten M, Sluijs KF, Gerlitz B, Grinnell BW, Roelofs JJ, Levi MM, van't Veer C, van der Poll T. Activated protein C ameliorates coagulopathy but does not influence outcome in lethal H1N1 influenza: a controlled laboratory study. Crit Care 2010;14:R65.
20. Schouten M, van der Sluijs KF, Roelofs JJ, Levi M, van't Veer C, van der Poll T. Factor V Leiden mutation does not affect coagulopathy or outcome in lethal H1N1 influenza. Eur Respir J 2010;36:1346-1354.
21. Xu J, Ji Y, Zhang X, Drake M, Esmon CT. Endogenous activated protein C signaling is critical to protection of mice from lipopolysaccaride-induced septic shock. J Thromb Haemost 2009;7:851-856.
22. Van Elden LJ, Nijhuis M, Schipper P, Schuurman R, van Loon AM. Simultaneous detection of influenza viruses A and B using real-time quantitative PCR. J Clin Microbiol 2001;39:196-200. (Pubitemid 32059590)
23. Jalbert LR, Rosen ED, Moons L, Chan JC, Carmeliet P, Collen D, Castellino FJ. Inactivation of the gene for anticoagulant protein C causes lethal perinatal consumptive coagulopathy in mice. J Clin Invest 1998;102:1481-1488. (Pubitemid 28492214)
24. Elms MJ, Bundesen PG, Rowbury D, Goodall S, Wakeham N, Rowell JA, Hillyard CJ, Rylatt DB. Automated-determination of cross-linked fibrin derivatives in plasma. Blood Coagul Fibrinolysis 1993;4:159-164. (Pubitemid 23064935)
25. Watanabe T, Yoshikawa H, Abe Y, Yamazaki S, Uehara Y, Abe T. Renal involvement in children with influenza A virus infection. Pediatr Nephrol 2003;18:541-544. (Pubitemid 36790094)
26. Keller TT, Van der Sluijs KF, De Kruif MD, Gerdes VEA, Meijers JCM, Florquin S, van der Poll T, Van Gorp ECM, Brandjes DPM, Büller HR, et al. Effects on coagulation and fibrinolysis induced by influenza in mice with a reduced capacity to generate activated protein C and a deficiency in plasminogen activator inhibitor type 1. Circ Res 2006;99:1261-1269. (Pubitemid 44808663)
27. + dendritic cells to reduce the mortality of endotoxemia in mice. J Clin Invest 2010;120:3167-3178.
28. Levi M, Dörffler-Melly J, Reitsma P, Buller H, Florquin S, van der Poll T, Carmeliet P. Aggravation of endotoxin-induced disseminated intravascular coagulation and cytokine activation in heterozygous protein-C-deficient mice. Blood 2003;101:4823-4827. (Pubitemid 36857741)
29. Lay AJ, Donahue D, Tsai MJ, Castellino FJ. Acute inflammation is exacerbated in mice genetically predisposed to a severe protein C deficiency. Blood 2007;109:1984-1991. (Pubitemid 46348196)
30. Murakami K, Okajima K, Uchiba M, Johno M, Nakagaki T, Okabe H, Takatsuki K. Activated protein C attenuates endotoxin-induced pulmonary vascular injury by inhibiting activated leukocytes in rats. Blood 1996;87:642-647. (Pubitemid 26030319)
31. Nick JA, Coldren CD, Geraci MW, Poch KR, Fouty BW, O'Brien J, Gruber M, Zarini S, Murphy RC, Kuhn K, et al. Recombinant human activated protein C reduces human endotoxin-induced pulmonary inflammation via inhibition of neutrophil chemotaxis. Blood 2004;104:3878-3885. (Pubitemid 39620133)
32. Robriquet L, Collet F, Tournoys A, Prangère T, Nevière R, Fourrier F, Guery BP. Intravenous administration of activated protein C in Pseudomonas-induced lung injury: impact on lung fluid balance and the inflammatory response. Respir Res 2006;22:41.